Fool.com
The World's Greatest Investing Community
Results 1 - 10 of 766 : 1 2 3 4 5 6 7 8 9 Next
After Rising 500%, What Did You Expect?
A nice licensing deal, but the stock was too high to begin with.
These are some of the most talked-about stocks around.
With double-digit gains, how could you not?
Behind the Business: 3 Questions for Vical
Vical provides key insights for shareholders and potential investors.
Great Call on MGM Mirage! What's Next?
This Fool made a great call on MGM Mirage -- check out these other recent picks.
Merck Makes a Mark on Good Cholesterol
Can't profit from fighting bad lipoproteins? Start boosting the good ones.
5-Star Stocks Poised to Pop: Abbott Labs
Market-trouncing returns could be written in these five stars.
Drug companies shape up, and it shows in their margins.
Eli Lilly adds another approval onto Cymbalta.
The Real Problem With the Public Health-Care Plan
It's the morphing part that should scare you.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK